-
Medical journals
- Career
Cough Therapy
We recommend
HPD 2024: Czech data from real-world practice confirm that mucolytic treatment can reduce COPD exacerbations, even in the future
24. 5. 2024 Source: Cough TherapyChronic obstructive pulmonary disease (COPD) is a global issue. Does it create the same burden everywhere? How does it contribute to premature deaths? How do women cope with COPD, and what significant problem does it pose for them? What factors contribute to it not being considered solely a smoker's disease? Why is it appropriate to add mucoactive agents when trying to eliminate COPD exacerbations? What emerged from early COPD screening conducted in the Czech Republic, and what do Czech real-world data show regarding the effectiveness of…
HPD 2024: Bronchitis as an Early Feature of PreCOPD, Role of Mucus Plugs in COPD, and New Findings on Their Exacerbations
Exacerbations of chronic obstructive pulmonary disease (COPD) significantly affect disease…24. 5. 2024 Source: Cough Therapy
Bacterial Biofilm as a Complication of Respiratory Disease Treatment
One of the unique characteristics of certain microorganisms is their ability to form organized…28. 11. 2023 Source: Cough Therapy
Articles on this topic
Recommend Erdostein for children when treating with amoxicillin – symptoms of cough improve in almost 50% of cases within 3 days
Acute respiratory infections are usually treated empirically in primary care as the causative…19. 1. 2021 Source: Cough Therapy
Levodropropizine vs. dextromethorphan: Which one to recommend to your patients and why?
Reducing cough intensity and nighttime awakenings, rapid onset of action, simple dosing…12. 11. 2020 Source: Cough Therapy
COVID Pneumonia: How Can Erdosteine Help and What Did a Clinical Study Suggest?
When patients who have recovered from COVID pneumonia begin home treatment, they are often far…12. 11. 2020 Source: Cough Therapy
Clinical Benefit of Mucolytics in the Treatment of Upper Respiratory Tract Infections
A new review based on published controlled and observational studies as well as real-world…6. 2. 2020 Source: Cough Therapy
Position of Levodropropizine in Cough Therapy
An international group of specialists focused in 2016–2017 on a detailed evaluation of current…15. 1. 2020 Source: Cough Therapy
E-courses on this topic
Authors: doc. MUDr. Vladimír Koblížek, Ph.D., MUDr. Mikuláš Skála, prof. MUDr. František Kopřiva, Ph.D., prof. MUDr. Roman Prymula, CSc., Ph.D.
Conferences news
Go to records
Go to records
12. 6. 2025 - 14. 6. 20250 records
Go to records
12. 6. 2025 - 14. 6. 20250 records
Go to records
21. 9. 2023 - 21. 9. 20233 records
Go to records
Most read on this topic- COVID Pneumonia: How Can Erdosteine Help and What Did a Clinical Study Suggest?
- Levodropropizine – a non-codeine antitussive with minimal side effects, contraindications, and drug interactions
- Treatment of Cough in Clinical Practice: Which Preparations Are Suitable and When?
- Levodropropizine vs. dextromethorphan: Which one to recommend to your patients and why?
- Conditions for the Use of Mucolytics in Children Are Tightening in Europe − Which Treatment Is Preferred?
- Viral or Bacterial Etiology? Old Question, New Methods...
Journal on this topic
Related topic
Interesting linksLogin#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career
